Analysts Viewpoint
Investing in Kyverna Therapeutics Inc. (KYTX): What You Must Know
In a filing, Kyverna Therapeutics Inc. revealed its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for reported $20.02 million
Menu
In a filing, Kyverna Therapeutics Inc. revealed its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for reported $20.02 million
Kyverna Therapeutics Inc.’s recent filing unveils that its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for reported $20.02 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Kyverna Therapeutics
Kyverna Therapeutics Inc.’s recent filing unveils that its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for reported $20.02 million